DavidL.JayeMD

Hematopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology & Laboratory Medicine, Emory University School of Medicine

Dr. Jaye is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
615 Michael St NE
Rm 105-B
Atlanta, GA 30322
Phone+1 404-712-2805

Fax+1 404-727-8538

Emory University School of MedicineFellowship, Hematopathology, 1997 - 1998
University of Alabama Medical CenterResidency, Pathology-Anatomic and Clinical, 1995 - 1997
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1991 - 1995
Washington University in St. Louis School of MedicineClass of 1991

PubMed

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Brooj Abro, Matthew J Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman
Blood. 2024-11-07
The unnecessary use of short tandem repeat testing on bone marrow samples in patients after 1 year following allogeneic hematopoietic stem cell transplant.
Anna B Morris, H Clifford Sullivan, Melanie S Wooten, Edmund K Waller, David L Jaye
American Journal of Clinical Pathology. 2024-11-04
4 citations
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann
American Journal of Hematology. 2024-03-01

Abstracts/Posters

Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
David L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
David L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
David L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

'Treason' by Immune System Cells Aids Growth of Multiple MyelomaOctober 8th, 2009

GI Inflammation: Novel G-Protein Coupled PMN ResponsesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006